EGFR and infection: Effective administration of these therapies early during infection, before the virus reaches its replication peak, is crucial and serves to prevent progression to severe disease.87–90 Our study underscores the potential of EGFR inhibitors in inhibiting the propagation of SARS-CoV-2 during the early stages of infection (Figs. 3–5, Supplementary Fig. 9).